Fluctuations in the Market Prices of Investment Securities
First written in FY2017. 2 of 10 entries say "Worsened", first in FY2020-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2019: 57 of 140 companies on the "Worse" side.
- FY2026Updated investment securities valuationAnnual report
「Consolidated fiscal year ended 31 March 2026 Investment securities 136,520 － － 136,520」
The fiscal year-end fair value of investment securities with quoted market prices was ¥136.52 million, up from ¥67.78 million in the previous fiscal year. The difference from the acquisition cost of ¥46.62 million was ¥89.89 million, and the valuation difference also increased. - FY2025Recognition of Gains on Sales of Investment SecuritiesAnnual report
「Gain on sale of investment securities - 10,662」
A gain on sale of investment securities of ¥10.662 million was recorded as extraordinary income in the consolidated fiscal year. The disclosure of actual results concerning the risk of fluctuations in the market prices of investment securities has been updated. - FY2022-Q3Cumulative gain on sales of investment securities updatedAnnual report
「Gain on sale of investment securities - 33,065」
A gain on sale of investment securities of ¥33.065 million was recorded as extraordinary income in the cumulative third quarter. - FY2022-Q1Recognition of Gains on Sales of Investment SecuritiesAnnual report
「Gain on sale of investment securities - 33,047」
A gain on sale of investment securities of ¥33.047 million was recorded as extraordinary income in the cumulative first quarter. - FY2021No impairment loss was recognised during the fiscal yearAnnual report
「Consolidated fiscal year (from 1 April 2020 to 31 March 2021): No applicable items.」
Although an impairment loss of ¥16.955 million on investment securities was recorded in the previous fiscal year, no impairment loss was recorded in the consolidated fiscal year. - FY2020WorsenedAnnual report
「Impairment loss on investment securities 16,955」
The risk of fluctuations in the market prices of investment securities materialized as an impairment loss of ¥16.955 million. The loss increased from the ¥957 thousand impairment loss in the previous fiscal year. - FY2020-Q3WorsenedAnnual report
「Impairment loss on investment securities - 16,955」
The risk of fluctuations in the market prices of investment securities materialized as an impairment loss of ¥16.955 million in the cumulative third quarter. The loss increased from the ¥957 thousand impairment loss recorded in the previous consolidated fiscal year. - FY2019MaterialisedAnnual report
「Impairment loss on investment securities 957」
The risk of fluctuations in the market prices of investment securities materialized as an impairment loss of ¥957 thousand in the consolidated fiscal year. The amount of investment securities recognized on the consolidated balance sheet also decreased from ¥116.6 million in the previous fiscal year to ¥90.96 million. - FY2018RestatedAnnual report
「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to market-price fluctuation risk.」
The Company continues to disclose the risk of fluctuations in the market prices of investment securities and its regular monitoring of fair values and issuers' financial condition. - FY2017First statedAnnual report
「Investment securities consist mainly of shares in companies with which the Company has business relationships and are exposed to market-price fluctuation risk.」
The Company holds ¥123.650 million in investment securities and discloses the risk of fluctuations in market prices. It regularly monitors fair values and the financial condition of issuers and reviews its holdings.